Oxford Vacmedix

Oxford Vacmedix founder Dr Shisong Jiang appointed as Senior Industrial Fellow at University of Oxford

Shisong Jiang is appointed to the newly created role of Senior Industrial Fellow in the Department of Oncology at the University of Oxford Oxford, UK – 9th November 2020 – FOR IMMEDIATE RELEASE Download PDF – Press Release-Senior Industrial Fellow 09-11-20 Oxford 9th November 2020; Oxford Vacmedix (OVM), the UK based biopharma company, focused on the development of a new generation of cancer vaccines, announced today that the founder of the company, Dr. Shisong Jiang, has been appointe...
Read More

Oxford Vacmedix announces collaboration to develop vaccine and diagnostic tests for Covid-19

Collaboration with the Nuffield Department of Medicine, University of Oxford will use recombinant overlapping peptide technology to develop a novel vaccine and diagnostic tests for Covid-19 Press Release Covid-19 project 12 May 2020 Oxford Vacmedix UK Limited (OVM), the UK-based biopharma company focusing on the development of cancer vaccines, announced today that it will use its proprietary recombinant overlapping peptide (ROP) technology to develop a new vaccine and diagnostic tests for Covid-...
Read More

Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8 and CD4 T Cells

Zhang et al – 2009 (view in PDF)...
Read More

Mouse Model for Pre-Clinical Study of Human Cancer Immunotherapy

Ya Z. et al – 2015 (view in PDF)...
Read More

WHO guidelines on nonclincial evaluation of vaccines

WHO Guideline – nonclinical_evaluation_vaccines_nov_2003...
Read More

A Bayesian design for phase I cancer therapeutic vaccine trials

Wang, Rosner and Roden – 2019 (view in PDF)...
Read More

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

van Poelgeest e al – 2013 (view in PDF)...
Read More

ELISpot for measuring human immune responses to vaccines

Slota et al – 2011 (view in PDF)...
Read More

Vaccine Immunology

Siegrist C-A – 2012...
Read More

Phase I Trial of Overlapping Long Peptides from a Tumor Self- Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

Sabbatini et al -2012 (view in PDF)...
Read More
en_GBEnglish